Guizhou Hongxiang Yixintang Pharmaceutical Chain Co., Ltd. announced that it will receive CNY 70,000,000 in an equity round of funding on May 28, 2019. The transaction will include participation from returning investor Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. (SZSE:002727). Post completion the registered capital of the company will increase from CNY 25,000,000 to CNY 95,000,000. Post transaction the investor will retain 100% stake in the company. The transaction has been approved by the board of directors of the company in its 14th session of the 4th directorate meeting and is subject to the approval of the shareholders of the company.